Literature DB >> 34470585

Hsa_circ_0060937 accelerates non-small cell lung cancer progression via modulating miR-195-5p/HMGB3 pathway.

Junfeng Xi1,2, Yunfeng Xi3, Zhibin Zhang2, Yanhong Hao2, Fei Wu1, Burong Bian4, Guangjun Hao4, Weiwei Li2, Shuqun Zhang1.   

Abstract

Circular RNAs (circRNAs) exert a critical effect on tumorigenesis and development. Our research aimed to clarify the function and underlying mechanism of circ_0060937 inNSCLC. The concentrations of circ_0060937, miR-195-5p and high-mobility group box 3 (HMGB3) were monitored via qRT-PCR and western blot assays. Additionally, cell proliferation, apoptosis, migration and invasion were assessed using CCK-8, colony formation, flow cytometry and transwell assays. Glycolysis was evaluated via detecting glucose uptake and lactate product. The association between miR-195-5p and circ_0060937/HMGB3 were validated using dual-luciferase reporter, RNA pull-down and RIP assays. Furthermore,in vivo experiment was performed to analyze tumorigenesis.Circ_0060937 and HMGB3 levels were elevated, whereas miR-195-5p level was dropped in NSCLC. Circ_0060937 down-regulation restrainedNSCLC cell proliferation, migration, invasion and glycolysis, and triggered apoptosis. Knockdown of circ_0060937 restrained NSCLC development via absorbing miR-195-5p. Circ_0060937 silencing inhibited NSCLC progression by mediating HMGB3. Besides, circ_0060937 depletion suppressed tumor growth in vivo.Circ_0060937 knockdown hindered NSCLC development and glycolysis via regulating miR-195-5p/HMGB3 pathway.

Entities:  

Keywords:  Circ_0060937; HMGB3; glycolysis; miR-195-5p; non-small cell lung cancer

Mesh:

Substances:

Year:  2021        PMID: 34470585      PMCID: PMC8565838          DOI: 10.1080/15384101.2021.1969203

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   5.173


  33 in total

1.  MiR-195-5p inhibits the cell migration and invasion of cervical carcinoma through suppressing ARL2.

Authors:  S-S Pan; H-E Zhou; H-Y Yu; L-H Xu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2019-12       Impact factor: 3.507

Review 2.  Circular RNAs: pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer.

Authors:  Chunyan Li; Lin Zhang; Guangping Meng; Qi Wang; Xuejiao Lv; Jie Zhang; Junyao Li
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-19       Impact factor: 4.553

Review 3.  The emerging role of circRNAs and their clinical significance in human cancers.

Authors:  Ling Qian; Shulin Yu; Zhen Chen; Zhiqiang Meng; Shenglin Huang; Peng Wang
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-06-19       Impact factor: 10.680

Review 4.  Non-small-cell lung cancer.

Authors:  Cesare Gridelli; Antonio Rossi; David P Carbone; Juliana Guarize; Niki Karachaliou; Tony Mok; Francesco Petrella; Lorenzo Spaggiari; Rafael Rosell
Journal:  Nat Rev Dis Primers       Date:  2015-05-21       Impact factor: 52.329

5.  The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression.

Authors:  Rui Yang; Lei Xing; Xiaying Zheng; Yan Sun; Xiaosong Wang; Junxia Chen
Journal:  Mol Cancer       Date:  2019-01-08       Impact factor: 41.444

Review 6.  CircRNAs in cancer metabolism: a review.

Authors:  Tao Yu; Yanfen Wang; Yu Fan; Na Fang; Tongshan Wang; Tongpeng Xu; Yongqian Shu
Journal:  J Hematol Oncol       Date:  2019-09-04       Impact factor: 17.388

7.  CircRNA hsa_circ_0087862 Acts as an Oncogene in Non-Small Cell Lung Cancer by Targeting miR-1253/RAB3D Axis.

Authors:  Lin Li; Ke Wan; Linkai Xiong; Shuang Liang; Fangfang Tou; Shanxian Guo
Journal:  Onco Targets Ther       Date:  2020-04-03       Impact factor: 4.147

8.  MiR-195-5p Inhibits Proliferation and Induces Apoptosis of Non-Small Cell Lung Cancer Cells by Targeting CEP55.

Authors:  Jianhua Luo; Junsu Pan; Yan Jin; Mengyuan Li; Miao Chen
Journal:  Onco Targets Ther       Date:  2019-12-24       Impact factor: 4.147

Review 9.  Metabolic Symbiosis in Chemoresistance: Refocusing the Role of Aerobic Glycolysis.

Authors:  Lisi Ma; Xiangyun Zong
Journal:  Front Oncol       Date:  2020-01-24       Impact factor: 6.244

10.  circFOXM1 promotes proliferation of non-small cell lung carcinoma cells by acting as a ceRNA to upregulate FAM83D.

Authors:  Chengtao Yu; Zhuoan Cheng; Shaohua Cui; Xiaowei Mao; Botai Li; Yujie Fu; Hui Wang; Haojie Jin; Qing Ye; Xiaojing Zhao; Liyan Jiang; Wenxin Qin
Journal:  J Exp Clin Cancer Res       Date:  2020-03-30
View more
  2 in total

1.  CircDLG1 promotes malignant development of non-small cell lung cancer through regulation of the miR-630/CENPF axis.

Authors:  Yingying Chen; Ying Zhang
Journal:  Strahlenther Onkol       Date:  2022-06-24       Impact factor: 3.621

2.  Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt/β-catenin signaling pathway and modulating the ratio of microRNA-195 (miR-195) to vascular endothelial growth factor A (VEGFA) expression.

Authors:  Linwen Zeng; Shaofeng Yuan; Pengfei Zhou; Jianming Gong; Xiangdong Kong; Ming Wu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.